Skip to main content

Table 2 Summary of the main parameters of the baseline laboratory and echocardiographic findings. There was no significant difference between the two groups regarding the laboratory and echocardiographic parameters

From: Analysis of cardiovascular mortality, bleeding, vascular and cerebrovascular events in patients with atrial fibrillation vs. sinus rhythm undergoing transfemoral Transcatheter Aortic Valve Implantation (TAVR)

Baseline laboratory

Total population (n = 257)

SR-group(n = 148)

AF-group(n = 109)

p Value

Hemoglobin (mmol/l)

7.5 ± 1.1

7.5 ± 1.1

7.4 ± 1.1

0.227

Creatinin (umol/l1)

108.1 ± 44.1

103.5 ± 37.1

114.2 ± 51.3

0.121*

Glomerular filtration rate CKD-EPI (ml/min1)

54.5 ± 19.2

54.9 ± 17.9

54.0 ± 20.9

0.718

Thrombocyte (Gpt/l)

222.5 ± 75.6

225.3 ± 77.5

218.6 ± 73.2

0.479

Echocardiographic parameters

Total population (n = 257)

SR-group (n = 148)

AF-group (n = 109)

p Value

Aortic valve area (cm2)

0.72 ± 0.17

0.72 ± 0.17

0.71 ± 0.16

0.799

Pulmonary hypertension (PaSP >55 mmHg)

23 (8.9%)

11 (7.4%)

12 (11.0%)

0.379

Ejection fraction (%)

46.1 ± 13.8

47.2 ± 13.7

44.5 ± 13.9

0.113

Ejection fraction <40%

59 (23.0%)

30 (20.3%)

29 (26.6%)

0.293

  1. 1Patients not requiring dialysis (n = 8; 3.1% or SR: n = 7; 4.7% AF: n = 1, 0.9%). * Test using log-transformed values
  2. All values correspond to the mean ± standard deviation or the number n (proportion in %)